Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Alphatec Holdings, Inc. (ATEC : NSDQ)
 
 • Company Description   
Alphatec Holdings, Inc. is a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. The Company's principal product offering includes a variety of spinal implant products and systems consisted of components, such as spine screws and rods, spinal spacers, plates, and various biologics offerings. Alphatec Holdings, Inc. is headquartered in Carlsbad, California.

Number of Employees: 867

 
 • Price / Volume Information   
Yesterday's Closing Price: $12.21 Daily Weekly Monthly
20 Day Moving Average: 1,934,025 shares
Shares Outstanding: 146.17 (millions)
Market Capitalization: $1,784.77 (millions)
Beta: 1.06
52 Week High: $12.82
52 Week Low: $4.88
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 28.12% 19.25%
12 Week 12.22% 21.25%
Year To Date 33.01% 44.11%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1950 CAMINO VIDA ROBLE
-
CARLSBAD,CA 92008
USA		 ph: 760-431-9286
fax: 800-922-1356		 investorrelations@atecspine.com http://www.atecspine.com
 
 • General Corporate Information   
Officers
Patrick S. Miles - Chairman and Chief Executive Officer
Evan Bakst - Director
David Demski - Director
David R. Pelizzon - Director
Keith Valentine - Director

Peer Information
Alphatec Holdings, Inc. (ABMD)
Alphatec Holdings, Inc. (DMDS)
Alphatec Holdings, Inc. (CPWY.)
Alphatec Holdings, Inc. (EQUR)
Alphatec Holdings, Inc. (ECIA)
Alphatec Holdings, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 02081G201
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/30/25
Share - Related Items
Shares Outstanding: 146.17
Most Recent Split Date: 8.00 (0.08:1)
Beta: 1.06
Market Capitalization: $1,784.77 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.20 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.88 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/30/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 2.78
EPS Growth
vs. Year Ago Period: -2.94%
vs. Previous Quarter: -52.17%
Sales Growth
vs. Year Ago Period: 22.17%
vs. Previous Quarter: -4.31%
ROE
03/31/25 - -
12/31/24 - -1,657.19
09/30/24 - -541.39
ROA
03/31/25 - -21.53
12/31/24 - -21.16
09/30/24 - -22.99
Current Ratio
03/31/25 - 2.75
12/31/24 - 2.73
09/30/24 - 2.32
Quick Ratio
03/31/25 - 1.67
12/31/24 - 1.58
09/30/24 - 1.15
Operating Margin
03/31/25 - -25.77
12/31/24 - -26.51
09/30/24 - -31.06
Net Margin
03/31/25 - -25.77
12/31/24 - -26.51
09/30/24 - -31.06
Pre-Tax Margin
03/31/25 - -25.76
12/31/24 - -26.50
09/30/24 - -31.15
Book Value
03/31/25 - -0.59
12/31/24 - -0.10
09/30/24 - -0.01
Inventory Turnover
03/31/25 - 1.14
12/31/24 - 1.10
09/30/24 - 1.08
Debt-to-Equity
03/31/25 - -
12/31/24 - -
09/30/24 - -
Debt-to-Capital
03/31/25 - -
12/31/24 - -
09/30/24 - -
 

Powered by Zacks Investment Research ©